Has Raymond Vivacqua received payments from drug or device companies?

Yes. Drug and device makers reported $8,441 in general payments to Raymond Vivacqua across 335 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Raymond Vivacqua did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Raymond Vivacqua come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Raymond Vivacqua

Hematology & Oncology · Upland, PANPI 1821089350

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.1% of the total across 335 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 57 manufacturers, the largest accounting for just 9.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,239 and has fallen 99.0% since, to $23 in 2024.

$8,441in general payments, 2019–2025

Across 335 payments — averaging $25.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$816
AstraZeneca$661
Incyte Corporation$550
ASD Specialty Healthcare, LLC$533
E.r. Squibb & Sons, L.L.C.$454
Astellas Pharma US Inc$431
plus $5K from 51 others

$7,063in research payments, 2019–2025

Across 4 payments — averaging $1765.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Celltrion, Inc.$6K
Incyte Corporation$813

What the payments were for

Food & beverage$7,68991%
Education$7529%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson(2 entities)	38	$816
AstraZeneca(2 entities)	18	$661
Incyte Corporation	14	$550
ASD Specialty Healthcare, LLC	6	$533
E.r. Squibb & Sons, L.L.C.	23	$454
Astellas Pharma US Inc	14	$431
Amgen	15	$313
Genentech USA, Inc.	12	$304
Bristol Myers Squibb	10	$263
Sanofi	12	$254
Seagen Inc.	10	$245
Daiichi Sankyo Inc.	9	$228
Pharmacyclics LLC, An Abbvie Company	12	$213
EMD Serono, Inc.	3	$200
Verastem, Inc.	5	$196
Gilead(2 entities)	7	$194
Bayer	7	$194
Merck	12	$181
AbbVie	7	$174
Galvanize Therapeutics, Inc	1	$152
GSK	4	$145
Lilly USA, LLC	7	$134
Novartis	8	$130
Pfizer	8	$121
Teva Pharmaceuticals USA, Inc.	6	$87
Rigel Pharmaceuticals, Inc.	5	$79
Beigene USA, Inc.	1	$76
Tersera Therapeutics LLC	5	$74
Blueprint Medicines Corporation	4	$74
Kyowa Kirin, Inc.	4	$72
Boehringer Ingelheim	2	$59
Eisai Inc.	3	$59
Global Blood Therapeutics, Inc.	4	$58
Takeda Pharmaceuticals U.S.A., Inc.	3	$57
Karyopharm Therapeutics Inc.	3	$57
Dendreon Pharmaceuticals LLC	2	$53
Regeneron Healthcare Solutions, Inc.	2	$49
Pharmaessentia USA Corporation	2	$45
Taiho Oncology, Inc.	3	$43
Puma Biotechnology, Inc.	2	$39
Coherus Oncology, Inc.	2	$37
Sobi, Inc	2	$35
Mylan Institutional Inc.	2	$33
Lexicon Pharmaceuticals, Inc.	2	$30
Secura Bio, Inc.	2	$26
Jazz Pharmaceuticals Inc.	1	$25
Abbott	1	$24
Morphosys, US Inc.	1	$22
Genmab U.S., Inc.	1	$21
Stemline Therapeutics Inc.	1	$17
Ipsen Biopharmaceuticals, Inc	1	$17
Adaptive Biotechnologies Corporation	1	$16
AMAG Pharmaceuticals, Inc.	1	$15
Tesaro, Inc.	1	$14
EUSA Pharma (US) LLC	1	$14
Deciphera Pharmaceuticals Inc.	1	$14
Servier Pharmaceuticals LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,441 in reported general payments places this provider in the 75th percentile of 682 hematology & oncology providers in Pennsylvania.

See all hematology & oncology providers in Pennsylvania →

Other hematology & oncology in Upland

Salman FazalPittsburgh$2.3M
Cyrus KhanPittsburgh$1.9M
Usama GergisAllentown$1.2M
Kit LuHarrisburg$810K
Henry FungPhiladelphia$730K
Alexander BarsoukPittsburgh$674K
Abdalla SholiWilliamsport$576K
Charu AggarwalPhiladelphia$541K
Tracey EvansEast Norriton$500K
Corey LangerPhiladelphia$492K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →